Merck & Co., Inc. (MRK)
111.90
-2.72
(-2.37%)
USD |
NYSE |
Apr 24, 16:00
111.95
+0.05
(+0.04%)
After-Hours: 20:00
Merck Total Liabilities (Quarterly) : 84.20B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 81.93B |
| Biogen, Inc. | 11.18B |
| Gilead Sciences, Inc. | 36.40B |
| Terns Pharmaceuticals, Inc. | 18.73M |
| Moderna, Inc. | 3.688B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 136.87B |
| Shareholders Equity (Quarterly) | 52.61B |
| Debt to Equity Ratio | 0.9606 |
| Current Ratio | 1.536 |
| Net Debt Paydown Yield | -0.95% |